Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZLAB
āļāļ·āđāļāļāļĢāļīāļĐāļąāļZai Lab Ltd
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 28, 2020
āļāļĩāļāļĩāđāļDu (Ying)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ1869
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 28
āļāļĩāđāļāļĒāļđāđBuilding B, 899 Halei Road, Pudong
āđāļĄāļ·āļāļSHANGHAI
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻChina
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ201203
āđāļāļĢāļĻāļąāļāļāđ862161632588
āđāļ§āđāļāđāļāļāđhttps://www.zailaboratory.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZLAB
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 28, 2020
āļāļĩāļāļĩāđāļDu (Ying)
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Dr. Richard B. Gaynor, M.D.
Dr. Richard B. Gaynor, M.D.
Independent Director
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Dr. Rafael G. Amado, M.D.
Dr. Rafael G. Amado, M.D.
President, Head of Global Research and Development
President, Head of Global Research and Development
Ms. Christine Chiou
Senior Vice President, Head - Investor Relations
Senior Vice President, Head - Investor Relations
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
ALPS Medical Breakthroughs ETF
Virtus LifeSci Biotech Products ETF
Invesco Golden Dragon China ETF
National Security Emerging Markets Index ETF
iShares Biotechnology ETF
Capital Group New Geography Equity ETF
ProShares Ultra Nasdaq Biotechnology
Invesco Nasdaq Biotechnology ETF
ActivePassive International Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Tema Oncology ETF
āļŠāļąāļāļŠāđāļ§āļ1.67%
ALPS Medical Breakthroughs ETF
āļŠāļąāļāļŠāđāļ§āļ1.19%
Virtus LifeSci Biotech Products ETF
āļŠāļąāļāļŠāđāļ§āļ0.97%
Invesco Golden Dragon China ETF
āļŠāļąāļāļŠāđāļ§āļ0.58%
National Security Emerging Markets Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.39%
iShares Biotechnology ETF
āļŠāļąāļāļŠāđāļ§āļ0.18%
Capital Group New Geography Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.15%
ProShares Ultra Nasdaq Biotechnology
āļŠāļąāļāļŠāđāļ§āļ0.12%
Invesco Nasdaq Biotechnology ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
ActivePassive International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ